Early onset of nephrotic syndrome after treatment with D-penicillamine in a patient with Wilson's disease

American Journal of Gastroenterology

Volumn 93, Issue 12, 1998, Pages 2544-2546

  Siafakas, Constantinos G ^a   Jonas, Maureen M ^a   Alexander, Stephen ^a   Herrin, John ^a   Furuta, Glenn T ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PENICILLAMINE; TRIENTINE;

ARTICLE; AUTOSOMAL RECESSIVE DISORDER; CASE REPORT; DRUG HYPERSENSITIVITY; DRUG MONITORING; DRUG RESPONSE; DRUG SAFETY; HUMAN; MALE; NEPHROSIS; NEPHROTIC SYNDROME; PRIORITY JOURNAL; SCHOOL CHILD; TREATMENT PLANNING; WILSON DISEASE;

CHELATING AGENTS; CHILD; HEPATOLENTICULAR DEGENERATION; HUMANS; MALE; NEPHROTIC SYNDROME; PENICILLAMINE; RETREATMENT; TIME FACTORS; TRIETHYLENETETRAMINE;

EID: 0032416624     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.1998.00715.x     Document Type: Article

References (10)

1. 1. Hall CL. The natural course of gold and penicillamine nephropathy: A long term study of 54 patients. Adv Exp Med Biol 1989;253: 247-56.
2. 2. Sternlieb I. Penicillamine and the nephrotic syndrome. Results in patients with hepatolenticular degeneration. JAMA 1966;1311-2.
3. 3. Klaassen CD. Heavy metals and heavy-metal antagonists. In: Goodman, Gilman, eds. The pharmacological basis of therapeutics. New York: Pergamon Press, 1990; 1610-2.
4. 4. Bell CL, Graziano RM. The safety of administration of penicillamine to penicillin-sensitive individuals. Arch Rheum 1983;26:801-3.
5. 5. Halverson PB, Kozin F, Bernhard GC, Goldman AL. Toxicity of penicillamine. A serious limitation to therapy in rheumatoid arthritis. JAMA 1978;240:1870-1.
6. 6. Scheinberg IH, Sternlieb I. Wilson's disease. In: Smith LH, ed. Major problems in internal medicine, vol 23. Philadelphia: WB Saunders, 1984:134-49.
7. 7. Walshe JM. Wilson's disease presenting with features of hepatic dysfunction: A clinical analysis of eighty seven patients. Q J Med 1989;263:253-63.
8. 8. Taylor HG, Samanta A. Penicillamine in rheumatoid arthritis. A problem of toxicity. Drug Safety 1992;7:46-53.
9. 9. Beacon PA, Tribe CR, Mackenzie JC, et al. Penicillamine nephropathy in rheumatoid arthritis. Q J Med 1976;45:661-84.
10. 10. Dubois RS, Roderson DO, Hambidge KM. Treatment of Wilson's disease with triethylene tetramine hydrochloride (Trientine). J Pediatr Gastroenterol Nutr 1990;10:77-81.